PRP19 Blocking Peptide
Catalog no. P-PRP19F · Research Use Only
$155 per 250 µg. Ships within 2–3 business days from the U.S.
P-PRP19F — affinity-purified Rabbit antibody against PRP19. Validated for Immunodepletion, Immunocompetition.
Specifications
| Catalog number | P-PRP19F |
|---|---|
| Target | PRP19 |
| Applications | Immunodepletion, Immunocompetition |
| Conjugate | Unconjugated |
| Immunogen | Synthetic peptide taken within amino acid region 200-300 on rat PRP19F protein. |
| Size | 250 µg |
| Storage | -20°C |
| UniProt | Q9JMJ4 |
About this target
PRP19 Blocking Peptide is the antigenic blocking peptide for the PRP19 antibody PRP19F-101AP. Pre-incubating the antibody with the peptide competes away specific binding, which helps confirm that a signal comes from the intended target. Supplied at 250 µg, for research use only. Ubiquitin-protein ligase which is a core component of several complexes mainly involved pre-mRNA splicing and DNA repair. Required for pre-mRNA splicing as component of the spliceosome. Core component of the PRP19C/Prp19 complex/NTC/Nineteen complex which is part of the spliceosome and participates in its assembly, its remodeling and is required for its activity. During assembly of the spliceosome, mediates 'Lys-63'-linked polyubiquitination of the U4 spliceosomal protein PRPF3. Ubiquitination of PRPF3 allows its recognition by the U5 component PRPF8 and stabilizes the U4/U5/U6 tri-snRNP spliceosomal complex. Subcellular location: Nucleus. Nucleus, nucleoplasm. Cytoplasm, cytoskeleton, spindle. Cytoplasm. Lipid droplet. Note=Nucleoplasmic in interphase cells. Irregularly distributed in anaphase cells.
Documents
Related products
- PRP19 Positive Control (PC-PRP19F)
- PRP19 Antibody (PRP19F-101AP)
- PRP19 Antibody BIOTIN (PRP19F-BIOTIN)
- PRP19 Antibody FITC (PRP19F-FITC)
FabGennix International, Inc., 9191 Kyser Way, Frisco, TX 75033. For research use only. Not for diagnostic or therapeutic use.